Skip to main content
PLOS Mental Health logoLink to PLOS Mental Health
. 2026 Sep 15;3(9):e0000717. doi: 10.1371/journal.pmen.0000717

The hidden burden of college life: Stress, sleep, and salivary biomarkers in students—A cross-sectional study

Hongyu Xu 1,2,☯,*, Zhiqiang Yan 3,☯, Xinyi Kong 1, Shuang Wu 1, Fei Shi 4, Qiong Ye 1, Zijin Li 1, Jia Lu 1, Juan Fang 5, Kexin Chen 1, Jiajun Bao 1, Yiyao Huang 1
Editor: Karli Montague-Cardoso6
PMCID: PMC13577347  PMID: 42743114

Abstract

Globally, university students face substantial psychological pressures, and stress-related mental health disorders are recognized as major public health concerns. While biomarkers such as cortisol have been extensively studied, integrated analyses of neuroendocrine-immune-circadian interactions remain limited. In this cross-sectional study with two complementary components, psychometric assessments of 637 undergraduates revealed that 90.4% experienced moderate-to-high perceived stress. These stress levels correlated with fatigue (r = 0.41, p < 0.01) and poor sleep quality (r = 0.35, p < 0.01). A second component involved laboratory-based diurnal biomarker profiling of 33 high-stress and low-stress participants, revealing stress-dependent physiological patterns. Specifically, high stress was associated with sympathetic activation (α-amylase↑), HPA axis dysregulation (altered diurnal cortisol patterns), circadian disruption (melatonin↑), and mucosal immune activation (IgA ↑ , lysozyme↑). The coupling of α-amylase and lysozyme suggested neuro-immune coordination (r = 0.52, p < 0.001). These findings indicate that salivary biomarker profiles are associated with perceived stress. Sleep quality and fatigue warrant further investigation as potential intervention targets in future longitudinal studies.

Introduction

Stress is a psychobiological response to perceived environmental threat [1]. Among undergraduates, stress arises from academic and social pressures that can impair cognitive resilience, academic performance, and increase dropout risk [2–4]. Dropout rates have risen, with a substantial proportion attributed to psychological concerns [5]. The World Health Organization estimated annual global productivity losses due to anxiety and depression at $1 trillion USD, a figure expected to rise [6].] Unmanaged stress can affect emotional and physical health, relationships, and quality of life, potentially creating a cycle of mental and academic decline [7,8]. The economic impact extends beyond individual well-being to institutional productivity [5]. Understanding the mechanisms linking stress to health outcomes in students is therefore a research priority.

Biomarkers are measurable characteristics that can be assessed objectively and reproducibly [9]. Perceived stress has been studied in relation to various physiological biomarkers. Cortisol, released by the adrenal glands in response to stress, is one of the most commonly examined [6–8]. As a primary mediator of mammalian stress adaptation, cortisol can be measured in blood, saliva, and hair, and shows altered patterns in chronic stress [10,11]. Chronic stress is associated with characteristic dysregulation patterns: (1) blunted diurnal rhythm, with reduced morning cortisol awakening response (CAR) and elevated nocturnal cortisol [12]; (2) hypocortisolism paradox, where initial hypercortisolemia progresses to adrenal exhaustion, flattening the cortisol slope [13]; and (3) decoupled reactivity, with exaggerated acute spikes despite basal hypocortisolism [14]. These alterations reflect HPA axis maladaptation, with clinical implications for immune and metabolic health [15].

Recent research has advanced understanding of stress physiology through distinct biomarker signatures across interconnected systems. Salivary α-amylase is a marker of sympathetic-adrenal-medullary (SAM) axis activation, rising rapidly via β-adrenergic signaling during acute stress to promote glycogen breakdown for energy mobilization [16,17]. Chromogranin A (CHGA), co-released with catecholamines from adrenal chromaffin cells, is involved in hormone storage and release; its proteolytic fragments influence autonomic function, complementing cortisol measurements [18,19].

Secretory immunoglobulin A (sIgA), produced by submucosal plasma cells, is suppressed by glucocorticoids during chronic stress, reducing epithelial translocation and compromising mucosal defense [19,20]. Lysozyme (LZM), an antimicrobial enzyme, shows dynamic stress-related changes and serves as an indicator of innate immune capacity [21]. Melatonin, synthesized by pinealocytes under suprachiasmatic nucleus (SCN) regulation, undergoes secretion phase shifts due to stress-induced corticotropin-releasing hormone (CRH), disrupting circadian entrainment of sleep-wake cycles via MT1/MT2 receptor downregulation [22]. This integrated biomarker panel—spanning neuroendocrine (α-amylase, CHGA), immune (sIgA, LZM), and circadian (melatonin) domains—allows multidimensional stress assessment. Stress physiology involves crosstalk among neuroendocrine, immune, and circadian systems [23,24]. Acute stress triggers synchronous SAM-HPA activation: norepinephrine stimulates α-amylase within minutes, while CRH initiates cortisol secretion [25]. However, sustained stress disrupts this coordination: chronic SAM activation can deplete HPA responsiveness, flattening cortisol rhythms despite persistent α-amylase elevation [26]. Melatonin phase shifts may desynchronize glucocorticoid oscillations and amplify nocturnal immunosuppression, potentially creating a cycle where disrupted sleep impairs stress recovery [27]. Thus, these biomarkers may reflect key points of dysregulation in stress pathophysiology.

The cyclical interaction between psychological stress, fatigue, and sleep disturbances is recognized as a pathway to mental health decline, though its mechanisms remain incompletely understood [28]. Evidence indicates that elevated stress impairs sleep and amplifies fatigue, creating a self-perpetuating cycle. While interventions targeting these factors show promise, progress has been limited by methodological constraints in capturing real-time psychobiological dynamics [29–31]. The stress-sleep relationship is bidirectional and complex. As highlighted by Gardani et al. (2022), stress can precipitate sleep difficulties through multiple mechanisms [12]. To address this gap, the present study employed a non-invasive psychobiological profiling approach using salivary biomarkers. This approach may help identify preclinical risk signatures and support early intervention [32].

Student stress is multifaceted, involving psychological, social, and environmental factors—including academic overload, developmental transitions, and social pressures [33,34]. Previous studies on undergraduate stress have been limited by reliance on either subjective self-reports or isolated biomarkers (e.g., cortisol alone), hindering a comprehensive understanding of how stress affects neuroendocrine, immune, and circadian systems simultaneously. The current study addressed this gap through an integrative cross-sectional design, combining validated questionnaires (PSS, PSQI, FSS) with parallel analyses of six salivary biomarkers: α-amylase (SAM axis), cortisol (HPA axis), melatonin (circadian regulation), IgA, lysozyme, and chromogranin A [13].

This study aimed to determine the prevalence of perceived stress, fatigue, and poor sleep quality among undergraduates, and to identify biomarkers associated with stress levels. Guided by psychophysiological models, we hypothesized that high perceived stress would be associated with: (a) elevated salivary α-amylase (SAM-axis hyperactivity) and cortisol (HPA-axis activation); and (b) disruption of circadian-immune biomarkers (melatonin phase shift, alterations in IgA and lysozyme). Specifically, we aimed to: (1) quantify the prevalence and interrelationships of perceived stress, fatigue, and poor sleep quality; (2) identify salivary biomarkers associated with heightened stress; and (3) characterize the physiological signature of stress in this population. This characterization may inform the selection of targets for future hypothesis-driven longitudinal studies and evidence-based interventions [35].

Materials and methods

Ethics Statement

The study protocol was approved by the Ethics Committee of Wenzhou-Kean University (Approval No. WKUIRB2023–008) and conducted in accordance with the WMA Declaration of Helsinki. All participants provided written informed consent after being informed of potential risks and benefits.

Participants

Participants maintained their regular eating, studying, and exercising routines. Except for coffee, carbonated beverages, and similar items, dietary intake was unrestricted. A total of 675 undergraduates were initially enrolled between March 3 and May 5, 2023. After excluding 38 incomplete responses, 637 participants (mean age 19.85 years, SD = 1.45) were included. Recruitment and questionnaire data collection occurred over three weeks within this period. Participants were recruited via email advertisements; participation was voluntary and confidential. Sessions included approximately 60 participants who completed questionnaires within 30 minutes starting at 3:00 PM in a classroom under the supervision of three certified evaluators [36]. The 3:00 PM time was chosen to minimize diurnal mood variations that could bias responses [16].

A random subset of 285 students was selected for biomarker analysis, with saliva collected at 3:00 PM. Of these, 23 samples were excluded due to insufficient volume or poor quality, leaving 262 samples for ELISA. Post-hoc power analysis indicated that with α = 0.05, the sample size of 637 for questionnaire analyses and 33 for diurnal profiling provided > 80% power to detect medium-to-large effect sizes (Cohen’s d ≥ 0.5) (Fig 1).

Fig 1. Overview of the study design and methodology.

Fig 1

Created with BioRender. Wong, A. (2026). https://BioRender.com/i61e911.

Instruments and data collection

The questionnaire packet included the PSS, FSS, PSQI, and a demographic survey covering age, gender, academic background, medication use, stress exposure, alcohol use, and gaming behavior. All assessments were administered in Chinese.

The PSS is a 14-item scale measuring perceived stress on a 5-point Likert scale (0 = never, 4 = very often). Total scores range from 14 to 70, with higher scores indicating greater perceived stress: low (14–28), moderate (29–42), high (43–56), and very high (57–70). The internal consistency of the PSS-14 was evaluated Cronbach’s alpha coefficient, yielding a reliability score of 0.78 for the overall scale [37,38].

The FSS is a 9-item scale assessing fatigue severity on a 7-point Likert scale (1 = strongly disagree, 7 = strongly agree). The total score is the mean of the nine items, with higher values reflecting greater fatigue [19]. Internal consistency was α = 0.88, and test-retest reliability was r = 0.84 [17].

The PSQI assessed subjective sleep quality over the preceding month [20]. This 19-item instrument yields seven component scores (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction), each scored 0–3, with a global score ranging from 0 to 21 [21,39]. Following established criteria, participants with PSQI > 5 were classified as having poor sleep quality [23]. Internal consistency, as measured by Cronbach's α, was 0.83 in this sample.

Participants for diurnal sample collection

Following questionnaire screening, 15 participants met the low-stress (LS) criteria (PSS ≤ 28, PSQI <5, and FSS < 4.0; all three required), and 18 met the high-stress (HS) criteria (at least one of: PSS ≥ 57, PSQI ≥ 5, or FSS ≥ 5). Inclusion criteria were: (1) no history of psychiatric or other diseases; (2) no long-term medication use. Initially, 40 participants met at least one HS criterion; of these, 22 were excluded due to ongoing psychotropic medication use (e.g., sertraline, trazodone), leaving 18 participants in the final HS group. All participants provided written informed consent and participation was voluntary and confidential.

Diurnal sample collection protocol

A total of 33 participants were accommodated in dedicated rooms at Wenzhou-Kean University (Wenzhou, China) for a 24‑h study period. Participants checked in on the evening prior to the experiment and were permitted to leave after the final sample collection. Outside the designated sampling times, they were allowed to engage in their usual activities.

EP tubes were stored in foil to protect samples from light. A designated experimenter collected samples at each time point, ensuring that melatonin and cortisol samples were obtained immediately upon waking.

Participants followed these pre-sampling guidelines: (1) no alcohol or caffeine 24 hours before; (2) no food or drink 1 hour before each session; (3) no strenuous exercise 3 hours before. All participants woke at 8:30 AM and rinsed their mouths with water. Saliva samples were collected at 9:00, 9:30, 10:00, 11:00, 12:00, 14:00, 16:00, 17:00, 18:00, 20:00, and 23:00 under technician supervision to minimize contamination. Participants provided 2 ml of saliva by passive drool into sterile tubes; samples were immediately placed on ice and stored at −80°C. Compliance was monitored through direct observation.

To minimize confounders, participants’ physical condition, stress, and fatigue were monitored. Demographic information (gender, height, weight) was recorded. Body temperature, blood pressure, and oxygen saturation were measured each morning and evening. Upon waking, participants completed a self-assessment form covering bedtime, sleep onset, wake time, sleep quality, and fatigue severity.

ELISA

Saliva samples were thawed on ice, centrifuged at 1,000 × g for 20 min at 4 ℃, and the supernatant was stored at -80 ℃. α-amylase, CHGA, IgA, and lysozyme were measured using sandwich ELISA, and cortisol and melatonin using competitive ELISA, following the manufacturer's protocols (Elabscience, Houston, TX, USA). Intra-assay precision was assessed by testing three samples (low, mid, and high concentrations) 20 times on a single plate; inter-assay precision was assessed by analyzing the same samples on three separate plates, with 20 replicates per plate.

Statistical analysis

Data analysis included: (1) descriptive statistics; (2) Pearson correlations among PSS, FSS, PSQI, and salivary biomarkers (Spearman for non-normal variables); (3) one-way ANOVA for group differences (gender, grade, major) with LSD post-hoc; (4) two-way ANOVA for gender × stress effects on PSQI and FSS; (5) repeated-measures ANOVA and generalized estimating equations (GEE) for time × group effects on biomarkers (log transformation for non-normal data); and (6) Random Forest machine learning (70% training/30% test) with GridSearchCV and 5-fold cross-validation. Prevalence rates used Wilson score 95% CIs; group differences used χ² tests.

Significance thresholds were p < 0.05, p < 0.01, and p < 0.001. Analyses used SPSS 26.0 and Python. Mauchly's test and Shapiro-Wilk test were applied; Greenhouse-Geisser correction was used when sphericity was violated.

Results

General perceived stress and fatigue state of the population

Of 675 invited participants, 637 (mean age 19.85 years, SD = 1.45) completed the questionnaires (response rate 94.1%); 38 were excluded due to incompleteness. The final sample included 217 men and 420 women: 38.1% freshmen, 24.2% sophomores, 21.0% juniors, and 16.6% seniors. Psychotropic drug use was reported by 23 (3.6%), 52 (8.2%) came from single‑parent families, and 174 (27.3%) had experienced traumatic events in the past six months (S1 Table).

Mean scores were: PSS = 39.18 (SD = 7.51), FSS = 4.87 (SD = 1.05), and PSQI = 5.61 (SD = 2.71), with no significant gender differences (PSS: F = 0.87, p = 0.35; FSS: F = 0.04, p = 0.83; PSQI: F = 0.06, p = 0.807). Moderate perceived stress was reported by 56.83% and high stress by 33.59% (Fig 2A). Poor sleep quality (PSQI > 5) was found in 47.57% (Fig 2B); PSQI scores ranged from 2 to 18. Fatigue was moderate (FSS 4-4.9) in 31.55% and severe (FSS ≥ 5) in 51.02% (Fig 2C).

Fig 2. Distribution of scores for the Perceived Stress Scale (PSS) (A), Pittsburgh Sleep Quality Index (PSQI) (B), and Fatigue Severity Scale (FSS) (C) among 637 students.

Fig 2

PSS categories were defined as low stress (14–28), moderate stress (29–42), high stress (43–56), and very high stress (57–70). Participants with PSQI > 5 were classified as having poor sleep quality. For the FSS, moderate fatigue was defined as 4–4.9 and severe fatigue as ≥ 5. Participants were divided into two groups based on PSS scores using K‑means clustering. A highly significant difference between the two groups was found (p < 0.001, D). Students with higher PSS scores also showed significantly higher PSQI (p < 0.001, E) and FSS (p < 0.001, F) scores. Although the box plots in panels E and F show some overlap in score distributions, differences in group means were statistically significant, as confirmed by two-way ANOVA. No significant gender differences were observed between the two groups.

As shown in S2 Table, MANOVA with LSD post-hoc tests revealed that freshmen had significantly lower FSS scores than other grades, indicating less fatigue. Sophomores had higher PSS scores than freshmen (p = 0.03), but not significantly different from juniors (p = 0.15) or seniors (p = 0.13). For PSQI, sophomores showed higher total scores and greater subjective sleep quality impairment than juniors (p < 0.05) and freshmen (p < 0.01), as well as greater sleep latency than freshmen and seniors, and the highest daytime dysfunction among all grades (p < 0.01). Both sophomores (p < 0.01) and seniors (p < 0.01) had greater sleep latency than freshmen.

Stress prevalence across academic years was: low 8.95%, moderate 56.83%, high 33.59%, and very high 0.63%, with no significant grade differences (χ² = 6.87, p = 0.65). Although sophomores had higher mean PSS scores than freshmen, the distribution across stress categories did not differ significantly by grade.

Perceived stress-related factors

PSS correlated positively with PSQI (r = 0.35, p < 0.01) and FSS (r = 0.41, p < 0.01); FSS also correlated with PSQI (r = 0.37, p < 0.01) (S3 Table). K-means clustering divided participants into LS (PSS 15–39) and HS (PSS 40–67) groups, with a significant group difference (Fig 2D, F = 1020.91, p < 0.001). Two-way ANOVA showed HS had higher FSS (mean 5.21 vs. 4.53, F = 68.74, p < 0.001; Fig 2E) and PSQI (mean 6.36 vs. 5.09, F = 28.22, p < 0.001; Fig 2F) than LS. No significant gender differences were found.

Saliva samples from 262 participants (3 PM) were analyzed for α-amylase, MT, CHGA, IgA, lysozyme, and cortisol; 23 samples were excluded due to poor quality. K-means clustering re-divided participants into LS (PSS 21–40) and HS (PSS 41–67). As shown in Fig 3, HS had higher levels of α-amylase (A), MT (B), IgA (D), lysozyme (E), and cortisol (F) than LS, but not CHGA (C). Females generally had lower α-amylase, MT, IgA, and lysozyme but higher cortisol; no consistent gender pattern was observed for CHGA. In an exploratory random-forest analysis (AUC = 0.76, 95% CI: 0.71-0.81), permutation importance (bootstrap, n = 1000) identified FSS (0.35, 95% CI: 0.30-0.40) and PSQI (0.21, 95% CI: 0.17-0.25) as the top predictors, followed by α-amylase (0.14, 95% CI: 0.10-0.18); model accuracy was 76% (Fig 4). Feature importance values were consistent: FSS (0.37), PSQI (0.22), and α-amylase (0.15) were most strongly associated with PSS, suggesting a potential role for these biomarkers in stress prediction that warrants further investigation.

Fig 3. Heat map illustrating the mean concentrations of salivary biomarkers: alpha-amylase (A, μg/ml), melatonin (MT; B, pg/ml), chromogranin A (CHGA; C, ng/ml), immunoglobulin A (IgA; D, μg/ml), lysozyme (LZM; E, μg/ml), and cortisol (F, μg/dl).

Fig 3

Groups were stratified by PSS score and gender. N = 262.

Fig 4. Machine learning analysis was conducted to assess the severity of perceived stress.

Fig 4

Panel (A) shows the feature importance of various factors, while the receiver operating characteristic (ROC) curve (B) indicates an area under the curve (AUC) of 0.76. N = 262.

The relationships among concentrations of salivary α-amylase, MT, CHGA, IgA, LZM, and cortisol

Pearson correlations among α-amylase, MT, CHGA, IgA, lysozyme, and cortisol are shown in S4 Table (N = 262). α-amylase showed statistically significant but very weak positive correlations with IgA (r = 0.14, p < 0.05), cortisol (r = 0.14, p < 0.05), and MT (r = 0.14, p < 0.05), likely attributable to the large sample size. In contrast, α-amylase was strongly correlated with lysozyme (r = 0.52, p < 0.001). MT concentrations showed positive correlations with IgA (r = 0.29, p < 0.001) and cortisol (r = 0.20, p < 0.01), and negatively with lysozyme (r = -0.18, p < 0.01).

K-means clustering classified participants into low (LA; mean ± SD = 8.98 ± 3.32 μg/ml) and high (HA; 20.10 ± 5.06 μg/ml) α-amylase groups. Two-way ANOVA showed HA had higher lysozyme (11.72 ± 5.91 vs. 7.50 ± 5.09 μg/ml; F = 30.01, p < 0.001; Fig 5E) and cortisol (27.49 ± 41.68 vs. 16.28 ± 24.57 μg/dl; F = 6.78, p < 0.05; Fig 5F) than LA. No significant differences were observed for IgA (F = 2.45, p = 0.12; Fig 5B), MT (F = 1.89, p = 0.17; Fig 5D), or CHGA (F = 0.15, p = 0.70; Fig 5C). No group-by-sex interactions were detected (all p > 0.05). Cortisol was higher in women than men (F = 8.71, p < 0.01).

Fig 5. Box plots showing the distribution of salivary biomarker concentrations stratified by alpha-amylase level (LA vs. HA).

Fig 5

Because no significant group-by-gender interaction was detected, data from male and female genders were combined. (A) alpha-amylase (μg/ml), (B) IgA (μg/ml), (C) CHGA (pg/ml), (D) MT (pg/ml), (E) lysozyme (μg/ml), and (F) cortisol (μg/dl). N = 262. Significance markers indicate comparisons between LA and HA groups (*p < 0.05, ***p < 0.001).

The diurnal course differences of salivary α-amylase, LZM, cortisol, MT, IgA, and CHGA

Diurnal profiles of α-amylase, lysozyme, cortisol, MT, IgA, and CHGA were assessed at 11 time points (9:00, 9:30, 10:00, 11:00, 12:00, 14:00, 16:00, 17:00, 18:00, 20:00, 23:00) in 33 participants: HS (n = 18, 8 men/10 women; PSS ≥ 57, PSQI ≥ 5, or FSS ≥ 5) and LS (n = 15, 6 men/9 women; PSS ≤ 28, PSQI < 5, and FSS < 4). No within-group gender differences were detected (p > 0.05).

α-amylase (Fig 6A–C): HS showed a significant rise within 30 min of waking; LS showed a similar rise after ~1 h. Both groups exhibited a similar pattern of alpha-amylase fluctuation over time: alpha-amylase level steadily increased: increasing until noon, dipping at 14:00, peaking at 20:00, then declining by 23:00. GEE confirmed significant time and group effects (Fig 6C). HS had higher levels than LS at 9:00, 9:30, 10:00, and 11:00, but levels converged by noon, with no differences at other time points.

Fig 6. Diurnal profiles of salivary alpha-amylase (A–C) and lysozyme (LZM; D–F) measured at 11 time points: 9:00 (wake-up), 9:30, 10:00, 11:00, 12:00, 14:00, 16:00, 17:00, 18:00, 20:00, and 23:00 (bedtime).

Fig 6

Participants were stratified into high-stress (HS, n = 18) and low-stress (LS, n = 15) groups based on questionnaire scores. The HS group met at least one of the following criteria: PSS ≥ 57, PSQI ≥ 5, or FSS ≥ 5. The LS group met all three criteria: PSS ≤ 28, PSQI < 5, and FSS < 4. Significance levels: *p < 0.05, **p < 0.01, ***p < 0.001.

Lysozyme (Fig 6D–F): In LS, levels gradually rose from 9:30–16:00, sharply increased at 17:00, peaked at 18:00, then declined at 20:00. In HS, a significant rise occurred only after 17:00, also peaking at 18:00. HS had higher lysozyme at 9:30, whereas LS had higher levels at 17:00, 18:00, 20:00, and 23:00 (Fig 6F).

Cortisol (Fig 7A–C): LS showed a clear diurnal pattern: rising 30 min after waking, stable until 16:00, peaking at 17:00, and remaining elevated until bedtime. HS showed greater variability, with a significant rise only at 14:00, followed by fluctuations and elevated levels after 20:00. HS had higher cortisol at 9:30 and 14:00; LS had higher levels from 17:00–23:00 (Fig 7C).

Fig 7. Diurnal profiles of salivary cortisol (G–I) and melatonin (MT; J–L) measured at the same 11 time points: 9:00 (wake-up), 9:30, 10:00, 11:00, 12:00, 14:00, 16:00, 17:00, 18:00, 20:00, and 23:00 (bedtime).

Fig 7

Participants were stratified into high-stress (HS, n = 18) and low-stress (LS, n = 15) groups based on questionnaire scores. The HS group met at least one of the following criteria: PSS ≥ 57, PSQI ≥ 5, or FSS ≥ 5. The LS group met all three criteria: PSS ≤ 28, PSQI < 5, and FSS < 4. Significance levels: *p < 0.05, **p < 0.01, ***p < 0.001.

MT (Fig 7D–F): Both groups showed similar patterns: higher levels after 14:00, peaking at 20:00, then declining by bedtime. LS also showed increases at 9:30 and 10:00. No significant group differences were observed at any time point (Fig 7F).

IgA (Fig 8A–C): IgA showed more variability than other biomarkers. LS had no consistent pattern, with significantly lower levels at 16:00 than at 9:00 (Fig 8A). HS peaked at 9:00, sharply declined by 9:30, reached the lowest level at 11:00, and returned to morning levels after 16:00 (Fig 8B). GEE showed HS had higher IgA at 9:00, while LS had higher levels at 11:00 (Fig 8C).

Fig 8. Diurnal profiles of salivary IgA (M–O) and chromogranin A (CHGA; P–R) measured at the same 11 time points: 9:00 (wake-up), 9:30, 10:00, 11:00, 12:00, 14:00, 16:00, 17:00, 18:00, 20:00, and 23:00 (bedtime).

Fig 8

Participants were stratified into high-stress (HS, n = 18) and low-stress (LS, n = 15) groups based on questionnaire scores. The HS group met at least one of the following criteria: PSS ≥ 57, PSQI ≥ 5, or FSS ≥ 5. The LS group met all three criteria: PSS ≤ 28, PSQI < 5, and FSS < 4. Significance levels: *p < 0.05, **p < 0.01, ***p < 0.001.

CHGA (Fig 8D–F): In LS, CHGA decreased after waking, rose 1 h later, stabilized between 11:00 and 16:00, then sharply declined to the lowest level at 17:00. In HS, CHGA steadily decreased until 17:00. GEE showed HS had higher CHGA at 9:30, with no other group differences (Fig 8F).

Discussion

Psychological stress is an important concern for undergraduates, as it can contribute to anxiety and depression, with consequences for health and societal productivity. Mental health disorders impose significant economic burdens through healthcare costs and lost productivity, yet stigma and limited access hinder help‑seeking [24,25]. This study examined the relationships among perceived stress, fatigue, and sleep quality in undergraduates using validated questionnaires and salivary biomarkers. The cross-sectional design allowed simultaneous assessment of subjective and objective stress indicators, capturing integrated psychobiological profiles that could inform targeted interventions. The observed correlations among perceived stress, fatigue, sleep quality, and salivary biomarkers suggest that such biomarkers may hold potential for guiding intervention strategies.

To our knowledge, this is among the first studies to systematically measure six salivary biomarkers—α-amylase, cortisol, melatonin, IgA, lysozyme, and chromogranin A—in parallel within a student population. Unlike earlier work that focused on single biomarkers (e.g., cortisol or α-amylase alone), this multi-metric approach provides a broader view of stress-related changes across neuroendocrine (SAM vs. HPA axes), immune (mucosal and antimicrobial), and circadian domains. Integrating data across these systems adds to the evidence supporting a network-based conceptualization of stress physiology. However, the cross-sectional nature of this study precludes causal interpretations, and longitudinal research is needed to clarify whether biomarker alterations precede or follow psychological distress.

The overall stress prevalence in this sample (moderate: 56.83%; high: 33.59%; total: 90.42%) was higher than rates reported in other student populations, such as 52.7% among Moroccan medical students [40] and 54–55% among medical students in Bangladesh [26]. Stress levels also varied by academic year: sophomores reported higher stress than freshmen, consistent with findings from Chinese medical students [41], though other studies have noted elevated stress in first-year students, attributed to academic, social, and financial transitions [42,43]. These grade-related differences likely reflect varying academic demands, social support, and adaptive capacity over the course of college, underscoring the importance of considering these factors when interpreting stress patterns across academic years.

While most cross-biomarker correlations were modest, α-amylase and lysozyme showed a robust association (r = 0.52), suggesting coordinated sympathetic-immune activation. α-amylase, a marker of SAM axis activity, is released via β-adrenergic signaling during acute stress; lysozyme, an innate immune enzyme, is similarly modulated by sympathetic activation through norepinephrine-stimulated neutrophil degranulation and NF-κB signaling. Their coupling may reflect enhanced oral mucosal antimicrobial defenses under stress. This α-amylase-lysozyme pair warrants further investigation as a candidate biomarker combination for non-invasive stress monitoring, though clinical applications would require additional validation. The cortisol profile in HS students—characterized by a blunted morning rise, a peak at 14:00, and elevated nocturnal levels—deviated from typical diurnal patterns. Prolonged stress may blunt HPA axis reactivity, flattening circadian cortisol rhythms through impaired negative feedback [27]. The 14:00 peak may represent a compensatory surge after morning HPA hypoactivation, consistent with reports linking chronic stress to altered cortisol pulsatility [44,45]. This pattern is consistent with a stress-induced HPA dysregulation phenotype. In addition, although melatonin secretion is normally minimal during daytime and further suppressed by sympathetic activation, the LS group showed elevated melatonin at 9:30–10:00. This may reflect stress-related chronodisruption, whereby prolonged HPA hyperactivity desynchronizes pineal melatonin release from light-dark cycles. Rodent models daytime melatonin surges under stress, possibly via impaired photic entrainment [41], but this mechanism awaits confirmation in humans.

Consistent with earlier reports [32, 33, 43], HS participants showed higher α-amylase, MT, IgA, lysozyme, and cortisol levels. α -amylase correlated strongly with PSS scores, supporting its relevance as a stress marker. Patients with anorexia nervosa, for example, show altered α-amylase responses to psychosocial stress [32], and portable devices now allow rapid stress assessment [34]. As a marker of sympathetic activity, α-amylase may hold promise for stress research [46]. Cortisol was also elevated in the HS group and has been linked to reduced negative affect [47], suggesting a potential emotional buffering function [40,48,49]. Changes in MT, IgA, and lysozyme may reflect stress-related modulation of circadian rhythms and immunity: elevated melatonin supports sleep-wake regulation [50], [51], increased IgA aids mucosal defense [52], and higher lysozyme enhances antimicrobial capacity [53]. Together, these elevations may represent an adaptive physiological response to stress. Although these biomarkers show promise for stress assessment and monitoring, further validation across diverse populations is needed [54].

α-amylase showed statistically significant but very weak positive correlations with IgA, cortisol, and MT, whereas a strong correlation was observed with lysozyme. MT was weakly positively correlated with IgA and cortisol, and weakly negatively correlated with lysozyme, consistent with prior findings. Given the large sample size, these weak correlations should be interpreted cautiously and not overemphasized as biologically strong relationships [33]. These findings are broadly consistent with previous reports: Rapson et al. also observed positive correlations among α-amylase, IgA, and cortisol [51], [55]. α-amylase and cortisol share similar diurnal fluctuations [52]; and α-amylase activity correlates with norepinephrine release, supporting its use as a non-invasive marker of sympathetic activation [56]. Changes in α-amylase and melatonin have been linked to stress and immune regulation—for example, exercise-induced α-amylase changes correlate with immune parameters [57,58], and melatonin modulates immune function [55,59]. The positive correlation between melatonin and IgA may reflect enhanced immune defense through modulation of immune cells or IgA synthesis [60,61], while its positive correlation with cortisol suggests involvement in HPA axis regulation [62,63]. The negative correlation between melatonin and lysozyme implies a complex immunomodulatory role, possibly via inhibition of lysozyme synthesis or secretion [64]. Collectively, these multi-biomarker correlations offer insights into stress-related physiological and immune processes and support the value of a combined analytical approach.

Diurnal comparisons between HS and LS groups revealed several differences. The HS group showed a higher morning α-amylase peak and a numerically blunted nighttime decline, although this difference was not statistically significant. The overall pattern may still suggest a tendency toward sustained sympathetic activation that warrants further investigation [65], possibly reflecting a shift toward sympathetic dominance that inhibits parasympathetic function [66–68]. This autonomic imbalance may contribute to the observed biomarker patterns [69] and has been associated with increased morning blood pressure and cardiovascular risk [70–72]. Nocturnal lysozyme fluctuations were attenuated in HS individuals, indicating reduced immune rhythmicity. Nighttime cortisol was lower in the HS group [45,73], consistent with HPA axis dysregulation and possibly an adaptive mechanism [74,75]. Melatonin circadian patterns did not differ between groups [76–78], likely reflecting its primary regulation by photoperiod via the SCN [79] and relative insensitivity to acute stress [80], with possible compensatory preservation of sleep cycles [81,82]. IgA levels were elevated in HS at 9:00 AM followed by a sharp decline [83], suggestive of short-term immune activation followed by depletion [84]. CHGA diurnal profiles also differed between groups; its release upon sympathetic activation [85] may be more pronounced in the morning [86]. These diurnal biomarker patterns may offer insights into stress-coping mechanisms and inform individualized stress management approaches [87].

The directionality of immune biomarker changes was unexpected. Contrary to the initial hypothesis that chronic stress would suppress IgA and lysozyme, we observed elevated levels of both in the HS group. This discrepancy could reflect several factors. First, stress in this student sample may be intermittent or acute-on-chronic, potentially activating mucosal immunity via SAM axis stimulation rather than producing the sustained glucocorticoid-mediated suppression typical of chronic stress. Second, the α-amylase-lysozyme correlation (r = 0.52) suggests coordinated neuro-immune activation, possibly reflecting an adaptive phase preceding immune depletion. Third, the 3 PM saliva collection time and the young, healthy sample may capture a distinct phase of stress-related immune modulation. These findings underscore the complexity of stress-immune interactions and suggest that immune activation may characterize certain stress states in otherwise healthy young adults. Longitudinal studies are needed to clarify whether elevated IgA and lysozyme represent an adaptive response preceding immune dysregulation, or a distinct phenotype separate from classical stress-induced immunosuppression.

Fatigue severity and sleep quality emerged as key risk factors for perceived stress in this sample. Interventions targeting these factors could help enhance students’ resilience and mental health. The interplay between fatigue, sleep, and stress has important health implications: poor sleep quality increases fatigue, which in turn worsens stress, creating a self-reinforcing cycle [88–90]. Thus, strategies to improve sleep quality and alleviate fatigue may be central to effective stress management in college populations [91].

Various interventions have been evaluated for reducing stress and improving sleep in college students. Psychological interventions yield moderate-to-large effects on sleep quality (g = 0.61) [92]. Environmental modifications, such as reducing noise disturbances, may also improve sleep and reduce anxiety [93]. Technology-based programs (e.g., STEPS-TECH) have shown benefits for sleep duration and nighttime awakenings. Physical activity enhances sleep quality and emotional well-being [94], indirectly reducing negative affect [95]. Music interventions, particularly self-administered formats, improve sleep and reduce anxiety in students, with longer durations associated with greater efficacy [96]. Combined approaches, such as positive self-hypnosis with resistance training, have also shown promise for stress management93. Overall, psychological support, environmental adjustments, exercise, music, and mind-body techniques have demonstrated effectiveness in improving sleep and reducing stress among college students. Given the strong interconnections among fatigue, sleep, and stress, multifaceted strategies addressing these domains are likely to be most beneficial for student health, highlighting the importance of managing these factors to promote both physical and mental well-being.

Several limitations should be considered. Self-reported data may introduce bias, and the sample may not fully represent the broader student population, limiting generalizability. Email-based recruitment could have introduced self-selection bias, as participation required active email engagement. The cross-sectional design precludes causal inferences, and the short study duration limits assessment of long-term effects. Circadian preference was not assessed; given the established links between eveningness, poor sleep, and stress reactivity, the observed biomarker-sleep relationships may be partly influenced by chronobiological differences. These limitations highlight the need for longitudinal studies and clinical validation.

This study highlights the associations among perceived stress, fatigue, and sleep quality in undergraduates, and their collective relevance to mental health. Given the cross-sectional design, the findings suggest that salivary α-amylase, particularly when considered together with self-reported fatigue, may be a promising candidate for further investigation as a stress-related biomarker in future longitudinal studies. While longitudinal validation is needed, these findings may help inform future research on support strategies addressing both psychological and physiological aspects of student stress. Despite its limitations, this study provides a preliminary framework for prospective cohort studies examining stress trajectories.

Supporting information

S1 Table. Sociodemographic of participants.

(DOCX)

pmen.0000717.s001.docx (14.7KB, docx)
S2 Table. FSS, PSS, and PSQI scores comparisons among the grades.

(DOCX)

pmen.0000717.s002.docx (17.1KB, docx)
S3 Table. Pearson correlation of PSQI, PSS, and FSS.

(DOCX)

pmen.0000717.s003.docx (12.9KB, docx)
S4 Table. Pearson correlation of alpha-amylase, IgA, CHGA, MT, LZM, and cortisol.

(DOCX)

pmen.0000717.s004.docx (13.9KB, docx)
S5 Table. Basic demographic information of participants recruited for diurnal sample collecting.

(DOCX)

pmen.0000717.s005.docx (18.4KB, docx)
S1 Fig. Scatter plots of MT, CHGA, IgA, LZM, and cortisol versus alpha‑amylase.

(TIF)

pmen.0000717.s006.tif (1.9MB, tif)
S1 Text. STROBE Statement—Checklist of items that should be included in reports of cross-sectional studies.

(DOCX)

pmen.0000717.s007.docx (29.8KB, docx)

Acknowledgments

We thank all participants for their contribution to this study.

Data Availability

The data contain potentially identifiable information from a specific participant group, and participants did not provide consent for public data sharing. All data access requests will be reviewed and approved by the ethics committee to ensure strict adherence to participant consent and privacy protections. This ensures that data sharing remains possible for legitimate scientific purposes while maintaining appropriate institutional oversight. Contact for data access: WKU Ethics Committee, Wenzhou-Kean University, orspdept@wku.edu.cn The corresponding author, Hongyu Xu, xuhy198169@163.com; hxu@kean.edu.

Funding Statement

This study was supported by the International Collaborative Research Foundation of WKU (Grant No. ICRP2023006 to HX), Wenzhou-Kean University International Faculty Research Support Program (Grant No. IRSPK202201 to HX), Student Partnering with Faculty Research Program (Grant Nos. WKUSPF2023029 to HX, WKUSPF2023030 to HX, and WKUSPF202439 to HX) and Wenzhou City’s Applied Basic Research (Grant No. GK20250047 to HX). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

References

  • 1.Molero Jurado MDM, Pérez-Fuentes MDC, Oropesa Ruiz NF, Simón Márquez MDM, Gázquez Linares JJ. Self-Efficacy and Emotional Intelligence as Predictors of Perceived Stress in Nursing Professionals. Medicina (Kaunas). 2019;55(6):237. doi: 10.3390/medicina55060237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gong Z, Wang H, Zhong M, Shao Y. College students’ learning stress, psychological resilience and learning burnout: status quo and coping strategies. BMC Psychiatry. 2023;23(1):389. doi: 10.1186/s12888-023-04783-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Moeller RW, Seehuus M, Peisch V. Emotional Intelligence, Belongingness, and Mental Health in College Students. Frontiers in Psychology. 2020;11:93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hamaideh SH. Stressors and reactions to stressors among university students. Int J Soc Psychiatry. 2011;57(1):69–80. doi: 10.1177/0020764009348442 [DOI] [PubMed] [Google Scholar]
  • 5.Ilen L, Feller C, Schneider M. Cognitive emotion regulation difficulties increase affective reactivity to daily-life stress in autistic adolescents and young adults. Autism. 2024;28(7):1703–18. doi: 10.1177/13623613231204829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pinto V, Sousa P, Catarino SO, Correia-Neves M, Minas G. Microfluidic immunosensor for rapid and highly-sensitive salivary cortisol quantification. Biosens Bioelectron. 2017;90:308–13. doi: 10.1016/j.bios.2016.11.067 [DOI] [PubMed] [Google Scholar]
  • 7.Kaur S, Gupta N, Malhotra BD. Recent developments in wearable & non-wearable point-of-care biosensors for cortisol detection. Expert Rev Mol Diagn. 2023;23(3):217–30. doi: 10.1080/14737159.2023.2184260 [DOI] [PubMed] [Google Scholar]
  • 8.Squires EC, McClure HH, Martinez CR Jr, Eddy JM, Jiménez RA, Isiordia LE, et al. Diurnal cortisol rhythms among Latino immigrants in Oregon, USA. J Physiol Anthropol. 2012;31(1):19. doi: 10.1186/1880-6805-31-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Iliadou E, Kikidis D, Pastiadis K, Plack CJ, Bibas A. Blood Prestin Levels in Normal Hearing and in Sensorineural Hearing Loss: A Scoping Review. Ear Hear. 2021;42(5):1127–36. doi: 10.1097/AUD.0000000000001045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.De Sio S, Letizia C, Petramala L, Saracino V, Cedrone F, Sanguigni P, et al. Work-related stress and cortisol levels: is there an association? Results of an observational study. Eur Rev Med Pharmacol Sci. 2018;22(24):9012–7. doi: 10.26355/eurrev_201812_16672 [DOI] [PubMed] [Google Scholar]
  • 11.Knight EL, Jiang Y, Rodriguez-Stanley J, Almeida DM, Engeland CG, Zilioli S. Perceived stress is linked to heightened biomarkers of inflammation via diurnal cortisol in a national sample of adults. Brain Behav Immun. 2021;93:206–13. doi: 10.1016/j.bbi.2021.01.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gardani M, Bradford DRR, Russell K, Allan S, Beattie L, Ellis JG, et al. A systematic review and meta-analysis of poor sleep, insomnia symptoms and stress in undergraduate students. Sleep Med Rev. 2022;61:101565. doi: 10.1016/j.smrv.2021.101565 [DOI] [PubMed] [Google Scholar]
  • 13.Xiao H, Wong DT. Proteomics and its applications for biomarker discovery in human saliva. Bioinformation. 2011;5(7):294–6. doi: 10.6026/97320630005294 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nader N, Chrousos GP, Kino T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J. 2009;23(5):1572–83. doi: 10.1096/fj.08-117697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.McEwen BS. Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin Neurosci. 2006;8(4):367–81. doi: 10.31887/DCNS.2006.8.4/bmcewen [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Díaz-Morales JF, Escribano C, Jankowski KS. Chronotype and time-of-day effects on mood during school day. Chronobiol Int. 2015;32(1):37–42. doi: 10.3109/07420528.2014.949736 [DOI] [PubMed] [Google Scholar]
  • 17.Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3. doi: 10.1001/archneur.1989.00520460115022 [DOI] [PubMed] [Google Scholar]
  • 18.Asah C, Sandahl H, Baandrup L, Carlsson J, Jennum P. Dream Enactment Behaviour in Post-Traumatic Stress Disorder. Eur J Psychotraumatol. 2025;16(1):2444743. doi: 10.1080/20008066.2024.2444743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cvetkovski S, Reavley NJ, Jorm AF. The prevalence and correlates of psychological distress in Australian tertiary students compared to their community peers. Aust N Z J Psychiatry. 2012;46(5):457–67. doi: 10.1177/0004867411435290 [DOI] [PubMed] [Google Scholar]
  • 20.Gunnell D, Caul S, Appleby L, John A, Hawton K. The incidence of suicide in university students in England and Wales 2000/2001-2016/2017: Record linkage study. J Affect Disord. 2020;261:113–20. [DOI] [PubMed] [Google Scholar]
  • 21.Zhang W, Liu Y, Yu J, Li D, Jia Y, Zhang Q, et al. Exercise improves sleep quality in older adults: a protocol for a systematic review and meta-analysis. BMJ Open. 2022;12(1):e047555. doi: 10.1136/bmjopen-2020-047555 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4 [DOI] [PubMed] [Google Scholar]
  • 23.Tapia JL, Puertas FJ, Duñabeitia JA. Study Protocol for a Randomized Controlled Trial Assessing the Effectiveness of Personalized Computerized Cognitive Training for Individuals With Insomnia. Front Behav Neurosci. 2022;16:779990. doi: 10.3389/fnbeh.2022.779990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Caruso A, Condello C, Maggi G, Vigna C, D’Antonio G, Gallo L, et al. How Psychophysical Stress Can Mediate the Effects of Anxiety and Depression on the Overall Quality of Life and Well-Being in Women Undergoing Hereditary Breast Cancer Screening. Cancers (Basel). 2024;16(21):3613. doi: 10.3390/cancers16213613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Müller R, Scholz M, Müller P, Burger P. Psychological stress and the need for stress management in veterinary studies. Schweiz Arch Tierheilkd. 2024;166(10):500–10. doi: 10.17236/sat00432 [DOI] [PubMed] [Google Scholar]
  • 26.Eva EO, Islam MZ, Mosaddek ASM, Rahman MF, Rozario RJ, Iftekhar AFMH, et al. Prevalence of stress among medical students: a comparative study between public and private medical schools in Bangladesh. BMC Res Notes. 2015;8:327. doi: 10.1186/s13104-015-1295-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bertollo AG, Grolli RE, Plissari ME, Gasparin VA, Quevedo J, Réus GZ, et al. Stress and serum cortisol levels in major depressive disorder: a cross-sectional study. AIMS Neurosci. 2020;7(4):459–69. doi: 10.3934/Neuroscience.2020028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Lipp A, Fothergill A. Nurses in abortion care: identifying and managing stress. Contemp Nurse. 2009;31(2):108–20. doi: 10.5172/conu.673.31.2.108 [DOI] [PubMed] [Google Scholar]
  • 29.Li X, Xue Q, Yi X, Liu J. The interaction of occupational stress, mental health, and cytokine levels on sleep in Xinjiang oil workers: A cross-sectional study. Front Psychiatry. 2022;13:924471. doi: 10.3389/fpsyt.2022.924471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Huisman C, Huisman E, Kort H. Technological Applications Contributing to Relieve Care Burden or to Sleep of Caregivers and People With Dementia: A Scoping Review From the Perspective of Social Isolation. Front Public Health. 2022;10:797176. doi: 10.3389/fpubh.2022.797176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zhou M, Gu X, Cheng K, Wang Y, Zhang N. Exploration of symptom clusters during hemodialysis and symptom network analysis of older maintenance hemodialysis patients: a cross-sectional study. BMC Nephrol. 2023;24(1):115. doi: 10.1186/s12882-023-03176-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Monteleone P, Scognamiglio P, Canestrelli B, Serino I, Monteleone AM, Maj M. Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa. Psychol Med. 2011;41(9):1963–9. doi: 10.1017/S0033291711000092 [DOI] [PubMed] [Google Scholar]
  • 33.Krahel A, et al. Salivary biomarkers (opiorphin, cortisol, amylase, and IgA) related to age, sex, and stress perception in a prospective cohort of healthy schoolchildren. Mediators Inflamm. 2021;2021:3639441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hsiao H-Y, Chen RLC, Chou C-C, Cheng T-J. Hand-held Colorimetry Sensor Platform for Determining Salivary α-Amylase Activity and Its Applications for Stress Assessment. Sensors (Basel). 2019;19(7):1571. doi: 10.3390/s19071571 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Piirainen V, Gutiérrez AM, Heinonen M, König E, Valros A, Junnikkala S. Salivary and serum haptoglobin, adenosine deaminase, and immunoglobulin G in growing pigs. Porcine Health Manag. 2024;10(1):21. doi: 10.1186/s40813-024-00368-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.English T, Carstensen LL. Emotional experience in the mornings and the evenings: consideration of age differences in specific emotions by time of day. Front Psychol. 2014;5:185. doi: 10.3389/fpsyg.2014.00185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96. doi: 10.2307/2136404 [DOI] [PubMed] [Google Scholar]
  • 38.Yang T, Huang H. Epidemiological study on psychological stress among urban residents during social transition. Chinese Journal of Epidemiology. 2003;24:760–4. [PubMed] [Google Scholar]
  • 39.Landry V, Siciliani E, Henry M, Payne RJ. Health-Related Quality of Life following Total Thyroidectomy and Lobectomy for Differentiated Thyroid Carcinoma: A Systematic Review. Curr Oncol. 2022;29(7):4386–422. doi: 10.3390/curroncol29070350 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Groffen DAI, Bosma H, Koster A, von Bonsdorff MB, Aspelund T, Eiriksdottir G, et al. A blunted diurnal cortisol response in the lower educated does not explain educational differences in coronary heart disease: findings from the AGES-Reykjavik study. Soc Sci Med. 2015;127:143–9. doi: 10.1016/j.socscimed.2014.09.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Reiter RJ, Rosales-Corral S, Sharma R. Circadian disruption, melatonin rhythm perturbations and their contributions to chaotic physiology. Adv Med Sci. 2020;65(2):394–402. doi: 10.1016/j.advms.2020.07.001 [DOI] [PubMed] [Google Scholar]
  • 42.Lu L, Ye C, Xu R, Feng H, Liu B. Psychological resilience and perceived stress among Chinese medical students: mediation between optimistic intelligence quotient and adversity quotient. BMC Med Educ. 2024;24(1):1358. doi: 10.1186/s12909-024-06287-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Paszynska E, Dmitrzak-Weglarz M, Tyszkiewicz-Nwafor M, Slopien A. Salivary alpha-amylase, secretory IgA and free cortisol as neurobiological components of the stress response in the acute phase of anorexia nervosa. World J Biol Psychiatry. 2016;17(4):266–73. doi: 10.3109/15622975.2016.1163419 [DOI] [PubMed] [Google Scholar]
  • 44.Linninge C, Jönsson P, Bolinsson H, Önning G, Eriksson J, Johansson G, et al. Effects of acute stress provocation on cortisol levels, zonulin and inflammatory markers in low- and high-stressed men. Biol Psychol. 2018;138:48–55. doi: 10.1016/j.biopsycho.2018.08.013 [DOI] [PubMed] [Google Scholar]
  • 45.Saban KL, Mathews HL, Bryant FB, O’Brien TE, Janusek LW. Depressive symptoms and diurnal salivary cortisol patterns among female caregivers of stroke survivors. Biol Res Nurs. 2012;14(4):396–404. doi: 10.1177/1099800412439458 [DOI] [PubMed] [Google Scholar]
  • 46.Schumacher S, Kirschbaum C, Fydrich T, Ströhle A. Is salivary alpha-amylase an indicator of autonomic nervous system dysregulations in mental disorders?--a review of preliminary findings and the interactions with cortisol. Psychoneuroendocrinology. 2013;38(6):729–43. doi: 10.1016/j.psyneuen.2013.02.003 [DOI] [PubMed] [Google Scholar]
  • 47.Het S, Schoofs D, Rohleder N, Wolf OT. Stress-induced cortisol level elevations are associated with reduced negative affect after stress: indications for a mood-buffering cortisol effect. Psychosom Med. 2012;74(1):23–32. doi: 10.1097/PSY.0b013e31823a4a25 [DOI] [PubMed] [Google Scholar]
  • 48.Wu H-S, Davis JE, Natavio T. Fatigue and disrupted sleep-wake patterns in patients with cancer: a shared mechanism. Clin J Oncol Nurs. 2012;16(2):E56-68. doi: 10.1188/12.CJON.E56-E68 [DOI] [PubMed] [Google Scholar]
  • 49.Eller NH, Netterstrøm B, Hansen AM. Psychosocial factors at home and at work and levels of salivary cortisol. Biol Psychol. 2006;73(3):280–7. doi: 10.1016/j.biopsycho.2006.05.003 [DOI] [PubMed] [Google Scholar]
  • 50.Aguilar-Raab C, Stoffel M, Hernández C, Rahn S, Moessner M, Steinhilber B, et al. Effects of a mindfulness-based intervention on mindfulness, stress, salivary alpha-amylase and cortisol in everyday life. Psychophysiology. 2021;58(12):e13937. doi: 10.1111/psyp.13937 [DOI] [PubMed] [Google Scholar]
  • 51.Lin Z, Chen P, Yuan Z, Yang L, Miao L, Wang H, et al. Fine particulate matter, airway inflammation, stress response, non-specific immune function and buccal microbial diversity in young adults. Environ Pollut. 2022;308:119692. doi: 10.1016/j.envpol.2022.119692 [DOI] [PubMed] [Google Scholar]
  • 52.Rapson A, Collman E, Faustini S, Yonel Z, Chapple IL, Drayson MT, et al. Free light chains as an emerging biomarker in saliva: Biological variability and comparisons with salivary IgA and steroid hormones. Brain Behav Immun. 2020;83:78–86. doi: 10.1016/j.bbi.2019.09.018 [DOI] [PubMed] [Google Scholar]
  • 53.Pettersson C, Karlsson H, Ståhlman M, Larsson T, Fagerberg B, Lindahl M, et al. LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome. J Intern Med. 2011;269(3):306–21. doi: 10.1111/j.1365-2796.2010.02292.x [DOI] [PubMed] [Google Scholar]
  • 54.Briguglio G, Teodoro M, Italia S, Verduci F, Pollicino M, Coco M, et al. Salivary Biomarkers and Work-Related Stress in Night Shift Workers. Int J Environ Res Public Health. 2021;18(6):3184. doi: 10.3390/ijerph18063184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Voronkov AE, Ivanov AA, Baskin II, Palyulin VA, Zefirov NS. Molecular modeling study of the mechanism of ligand binding to human melatonin receptors. Dokl Biochem Biophys. 2005;403:284–8. doi: 10.1007/s10628-005-0093-8 [DOI] [PubMed] [Google Scholar]
  • 56.Petrakova L, Boy K, Mittmann L, Möller L, Engler H, Schedlowski M. Salivary alpha-amylase and noradrenaline responses to corticotropin-releasing hormone administration in humans. Biol Psychol. 2017;127:34–9. doi: 10.1016/j.biopsycho.2017.04.016 [DOI] [PubMed] [Google Scholar]
  • 57.Murase Y, Shimizu K, Tanimura Y, Hanaoka Y, Watanabe K, Kono I, et al. Salivary extracellular heat shock protein 70 (eHSP70) levels increase after 59 min of intense exercise and correlate with resting salivary secretory immunoglobulin A (SIgA) levels at rest. Cell Stress Chaperones. 2016;21(2):261–9. doi: 10.1007/s12192-015-0656-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kapoor MP, Sugita M, Kawaguchi M, Timm D, Kawamura A, Abe A, et al. Influence of iron supplementation on fatigue, mood states and sweating profiles of healthy non-anemic athletes during a training exercise: A double-blind, randomized, placebo-controlled, parallel-group study. Contemp Clin Trials Commun. 2023;32:101084. doi: 10.1016/j.conctc.2023.101084 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Song Y-M, Chen M-D. Effects of melatonin administration on plasma leptin concentration and adipose tissue leptin secretion in mice. Acta Biol Hung. 2009;60(4):399–407. doi: 10.1556/ABiol.60.2009.4.6 [DOI] [PubMed] [Google Scholar]
  • 60.Nous A, Wittens MMJ, Vermeiren Y, De Deyn PP, Van Broeckhoven C, Nagels G, et al. Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline. J Alzheimers Dis. 2021;83(2):693–704. doi: 10.3233/JAD-210562 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Zivieri R, Borziani F, Strazzanti A, Fragomeni A, Pacini N. Effect of Indolic-Amide Melatonin on Blood Cell Population: A Biophysical Gaussian Statistical Analysis. Molecules. 2018;23(6):1378. doi: 10.3390/molecules23061378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Corbalán-Tutau D, Madrid JA, Nicolás F, Garaulet M. Daily profile in two circadian markers “melatonin and cortisol” and associations with metabolic syndrome components. Physiol Behav. 2014;123:231–5. doi: 10.1016/j.physbeh.2012.06.005 [DOI] [PubMed] [Google Scholar]
  • 63.Perego R, Proverbio D, Spada E. Increases in heart rate and serum cortisol concentrations in healthy dogs are positively correlated with an indoor waiting-room environment. Vet Clin Pathol. 2014;43(1):67–71. doi: 10.1111/vcp.12118 [DOI] [PubMed] [Google Scholar]
  • 64.Nunez PRM, Honorio-França AC, Geiger SM, Guedes M, Fagundes DLG, Magalhães AM, et al. Prevalence of enteroparasitic infections and related hormonal and immunological repercussions that may compromise students’ physical performance. Trop Biomed. 2020;37(3):763–77. doi: 10.47665/tb.37.3.763 [DOI] [PubMed] [Google Scholar]
  • 65.Giessner S, Ramaker ME, Blew K, Crawford ML, Grant RP, Bain JR, et al. Disrupted Circadian Rhythm of Epinephrine in Males With Youth-Onset Type 2 Diabetes. J Endocr Soc. 2022;7(2):bvac190. doi: 10.1210/jendso/bvac190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Xiaoming X, Ming A, Su H, Wo W, Jianmei C, Qi Z, et al. The psychological status of 8817 hospital workers during COVID-19 Epidemic: A cross-sectional study in Chongqing. J Affect Disord. 2020;276:555–61. doi: 10.1016/j.jad.2020.07.092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Caliman-Sturdza OA, Gheorghita R, Lobiuc A. Neuropsychiatric Manifestations of Long COVID-19: A Narrative Review of Clinical Aspects and Therapeutic Approaches. Life (Basel). 2025;15(3):439. doi: 10.3390/life15030439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Shaygan M, Yazdani Z, Valibeygi A. The effect of online multimedia psychoeducational interventions on the resilience and perceived stress of hospitalized patients with COVID-19: a pilot cluster randomized parallel-controlled trial. BMC Psychiatry. 2021;21(1):93. doi: 10.1186/s12888-021-03085-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Chouchou F, Pichot V, Pépin JL, Tamisier R, Celle S, Maudoux D, et al. Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects: the PROOF-SYNAPSE study. Eur Heart J. 2013;34(28):2122–31, 2131a. doi: 10.1093/eurheartj/eht208 [DOI] [PubMed] [Google Scholar]
  • 70.Grassi G, et al. Sympathetic nerve traffic activation in essential hypertension and its correlates: systematic reviews and meta-analyses. Hypertension. 2018;72:483–91. [DOI] [PubMed] [Google Scholar]
  • 71.Welch MG, Hofer MA, Brunelli SA, Stark RI, Andrews HF, Austin J, et al. Family nurture intervention (FNI): methods and treatment protocol of a randomized controlled trial in the NICU. BMC Pediatr. 2012;12:14. doi: 10.1186/1471-2431-12-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Alabdulgader A, McCraty R, Atkinson M, Dobyns Y, Vainoras A, Ragulskis M, et al. Long-Term Study of Heart Rate Variability Responses to Changes in the Solar and Geomagnetic Environment. Sci Rep. 2018;8(1):2663. doi: 10.1038/s41598-018-20932-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Chouinard A-M, Larouche E, Audet M-C, Hudon C, Goulet S. Mindfulness and psychoeducation to manage stress in amnestic mild cognitive impairment: A pilot study. Aging Ment Health. 2019;23(9):1246–54. doi: 10.1080/13607863.2018.1484890 [DOI] [PubMed] [Google Scholar]
  • 74.Badanes LS, Watamura SE, Hankin BL. Hypocortisolism as a potential marker of allostatic load in children: associations with family risk and internalizing disorders. Dev Psychopathol. 2011;23(3):881–96. doi: 10.1017/S095457941100037X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Petrullo LA, Mandalaywala TM, Parker KJ, Maestripieri D, Higham JP. Effects of early life adversity on cortisol/salivary alpha-amylase symmetry in free-ranging juvenile rhesus macaques. Horm Behav. 2016;86:78–84. doi: 10.1016/j.yhbeh.2016.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Zieba DA, Klocek B, Williams GL, Romanowicz K, Boliglowa L, Wozniak M. In vitro evidence that leptin suppresses melatonin secretion during long days and stimulates its secretion during short days in seasonal breeding ewes. Domest Anim Endocrinol. 2007;33(3):358–65. doi: 10.1016/j.domaniend.2006.06.004 [DOI] [PubMed] [Google Scholar]
  • 77.Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, Reiter RJ. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opin Investig Drugs. 2012;21(6):819–31. doi: 10.1517/13543784.2012.681045 [DOI] [PubMed] [Google Scholar]
  • 78.Lankford DA. Tasimelteon for insomnia. Expert Opin Investig Drugs. 2011;20(7):987–93. doi: 10.1517/13543784.2011.583235 [DOI] [PubMed] [Google Scholar]
  • 79.Pévet P. The internal time-giver role of melatonin. A key for our health. Rev Neurol (Paris). 2014;170(11):646–52. doi: 10.1016/j.neurol.2014.05.008 [DOI] [PubMed] [Google Scholar]
  • 80.Cuesta M, Boudreau P, Dubeau-Laramée G, Cermakian N, Boivin DB. Simulated Night Shift Disrupts Circadian Rhythms of Immune Functions in Humans. J Immunol. 2016;196(6):2466–75. doi: 10.4049/jimmunol.1502422 [DOI] [PubMed] [Google Scholar]
  • 81.Mulder H, Nagorny CLF, Lyssenko V, Groop L. Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia. 2009;52(7):1240–9. doi: 10.1007/s00125-009-1359-y [DOI] [PubMed] [Google Scholar]
  • 82.Kim T-H, Cho S-G. Melatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasiveness. Oncol Lett. 2017;14(2):2511–6. doi: 10.3892/ol.2017.6434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Marques-Feixa L, Castro-Quintas Á, Palma-Gudiel H, Romero S, Morer A, Rapado-Castro M, et al. Secretory immunoglobulin A (s-IgA) reactivity to acute psychosocial stress in children and adolescents: The influence of pubertal development and history of maltreatment. Brain Behav Immun. 2022;103:122–9. doi: 10.1016/j.bbi.2022.04.010 [DOI] [PubMed] [Google Scholar]
  • 84.Quinti I, Mortari EP, Fernandez Salinas A, Milito C, Carsetti R. IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection. Front Cell Infect Microbiol. 2021;11:655896. doi: 10.3389/fcimb.2021.655896 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Gomaa AM, Galal HM, Abou-Elgait AT. Neuroprotective effects of melatonin administration against chronic immobilization stress in rats. Int J Physiol Pathophysiol Pharmacol. 2017;9(2):16–27. [PMC free article] [PubMed] [Google Scholar]
  • 86.Subramanian L, Khan AA, Allu PKR, Kiranmayi M, Sahu BS, Sharma S, et al. A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders. J Biol Chem. 2017;292(34):13970–85. doi: 10.1074/jbc.M117.778134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Pundir M, Papagerakis S, De Rosa MC, Chronis N, Kurabayashi K, Abdulmawjood S, et al. Emerging biotechnologies for evaluating disruption of stress, sleep, and circadian rhythm mechanism using aptamer-based detection of salivary biomarkers. Biotechnol Adv. 2022;59:107961. doi: 10.1016/j.biotechadv.2022.107961 [DOI] [PubMed] [Google Scholar]
  • 88.Wu Z, Zhao P, Peng J, Fang L, Ding J, Yan G, et al. A Patient-Controlled Intravenous Analgesia With Tramadol Ameliorates Postpartum Depression in High-Risk Woman After Cesarean Section: A Randomized Controlled Trial. Front Med (Lausanne). 2021;8:679159. doi: 10.3389/fmed.2021.679159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Reeve S, Sheaves B, Freeman D. Sleep Disorders in Early Psychosis: Incidence, Severity, and Association With Clinical Symptoms. Schizophr Bull. 2019;45(2):287–95. doi: 10.1093/schbul/sby129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Tang X, Pei Y, Wang X, Jiang L, Liu P, Chen Y, et al. Mental health and fatigue status of the medical workforce during the COVID-19 outbreak in the Yangzhou city, China. Front Psychiatry. 2022;13:1018069. doi: 10.3389/fpsyt.2022.1018069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Park H-C, Oh J. The relationship between stress and sleep quality: The mediating effect of fatigue and dizziness among patients with cardiovascular disease. Medicine (Baltimore). 2023;102(20):e33837. doi: 10.1097/MD.0000000000033837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Saruhanjan K, Zarski A-C, Bauer T, Baumeister H, Cuijpers P, Spiegelhalder K, et al. Psychological interventions to improve sleep in college students: A meta-analysis of randomized controlled trials. J Sleep Res. 2021;30(1):e13097. doi: 10.1111/jsr.13097 [DOI] [PubMed] [Google Scholar]
  • 93.Peltz JS. The day-to-day impact of nighttime noise disturbances on college students’ psychological functioning. J Am Coll Health. 2022;70(7):2061–9. doi: 10.1080/07448481.2020.1842422 [DOI] [PubMed] [Google Scholar]
  • 94.Mu F-Z, Liu J, Lou H, Zhu W-D, Wang Z-C, Li B. Influence of physical exercise on negative emotions in college students: chain mediating role of sleep quality and self-rated health. Front Public Health. 2024;12:1402801. doi: 10.3389/fpubh.2024.1402801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Yuan MZ, Chen CC, Chen IS, Yang CC, Hsu CH. Research on the impact of regular exercise behavior of college students on academic stress and sleep quality during the COVID-19 pandemic. Healthcare (Basel). 2022;10:2534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Hu S-P, Yang Y-M, Chen W-H, Lu S-S, Niu T, Xia Y-Z, et al. Effect of sleep ambient music on sleep quality and mental health in college students: a self-controlled study. Front Psychol. 2023;14:1171939. doi: 10.3389/fpsyg.2023.1171939 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Ment Health. 2026 Sep 15;3(9):e0000717. doi: 10.1371/journal.pmen.0000717.r001

Author response to Decision Letter 0


Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

17 Dec 2025

PLOS Ment Health. doi: 10.1371/journal.pmen.0000717.r002

Decision Letter 0

Karli Montague-Cardoso

26 Mar 2026

PMEN-D-25-00591

The Hidden Burden of College Life: Stress, Sleep, and Salivary Biomarkers in Students

PLOS Mental Health

Dear Dr. Xu,

Thank you for submitting your manuscript to PLOS Mental Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Mental Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please ensure that you fully address all of the points raised, which you can find at the end of this email.

Please submit your revised manuscript by Apr 24 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at mentalhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pmen/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Karli Montague-Cardoso

Staff Editor

PLOS Mental Health

Journal Requirements:

1. Please provide a detailed online Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

a) State the initials, alongside each funding source, of each author to receive each grant. For example: “This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM).”

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

For more information, please go to our submission guidelines:

https://journals.plos.org/mentalhealth/s/submission-guidelines#loc-financial-disclosure-statement

2. Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well.

3. In the online submission form, you indicated that "The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.".

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either

a) In a public repository,

b) Within the manuscript itself, or

d) Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons by return email and your exemption request will be escalated to the editor for approval. Your exemption request will be handled independently and will not hold up the peer review process, but will need to be resolved should your manuscript be accepted for publication. One of the Editorial team will then be in touch if there are any issues.

For further assistance, you may go to: http://journals.plos.org/mentalhealth/s/data-availability

4. Please provide separate main figure files in .tif or .eps format only and ensure that all files are under our size limit of 10MB.

For more information about how to convert your figure files please see our guidelines: https://journals.plos.org/mentalhealth/s/figures

5. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files before or after the references list.

6. Some material included in your submission may be copyrighted. According to PLOS’s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOS’s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form.

Please respond directly to this email or email the journal office and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility.

Potential Copyright Issues:

Figure 1: Please confirm whether you drew the images / clip-art within the figure panels by hand. If you did not draw the images, please provide (a) a link to the source of the images or icons and their license / terms of use; or (b) written permission from the copyright holder to publish the images or icons under our CC-BY 4.0 license. Alternatively, you may replace the images with open source alternatives. See these open source resources you may use to replace images / clip-art:

- https://commons.wikimedia.org

- https://openclipart.org/

7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Mental Health’s publication criteria?>

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: Yes

Reviewer #2: I don't know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: General information

- The journal requires double spacing.

- I recommend that authors use the same font and font size for the main text and the bibliography (main text: Times 12/bibliography: Calibri 14).

- To comply with the journal’s submission guidelines, the References section will need to be reformatted, mainly to adjust the authors’ punctuation and to organize the publication details in the correct chronological format.

- Materials and Methods? Instead of methods

- Ending section

The following elements are required, in order:

Acknowledgments

References

Supporting information captions (if applicable)

- Figure captions are inserted immediately after the first paragraph in which the figure is cited. Figure files are uploaded separately.

Tables are inserted immediately after the first paragraph in which they are cited.

Supporting information files are uploaded separately.

- Add short title no longer than 70 characters

- Fix bibliography format. Correct example Published articles

Hou WR, Hou YL, Wu GF, Song Y, Su XL, Sun B, et al. cDNA, genomic sequence cloning and overexpression of ribosomal protein gene L9 (rpL9) of the giant panda (Ailuropoda melanoleuca). Genet Mol Res. 2011;10: 1576-1588.

Abstract

- The abstract states that “90.4% experienced clinically significant stress.” However, when reviewing the results in the body of the manuscript, that 90.4% is broken down into ‘moderate’ (56.83%) and “high” (33.59%) stress. Labeling overall moderate stress as “clinically significant” in the abstract could be considered an overly strong or alarmist statement that does not accurately reflect the categorization of the PSS-14 scale detailed in the methods.

- The abstract indicates HPA axis hyperactivity by stating “cortisol↑.” While useful for summarizing, the main text details that students with high stress show an atypical diurnal pattern (lack of normal morning peak and an anomalous peak at 2:00 p.m., along with elevated nighttime levels). A simple “cortisol↑” misses the nuance that the actual finding is an alteration in the diurnal rhythm rather than a simple basal increase.

- The abstract is very competent and appealing to readers. Is necesary a minor adjustment in the wording about “clinically significant stress” to better align it with the results data,

Introduction

- Lines 57-60: I suggest that the authors ensure that all theoretical statements in the “Introduction” section are properly supported with their respective bibliographic references.

- Lines 76-112: This paragraph is very long (it occupies almost 36 continuous lines in the original manuscript). The density of medical acronyms and signaling cascades causes cognitive fatigue in the reader. I recommend that the authors strategically divide the paragraph or summarize the information.

- Lines 125-130: The final results of the study should not be revealed in the Introduction. This section is for stating the state of the art of the study idea.

- Lines 123-125: The paragraph states that the study proposes a “novel self-assessment paradigm” that allows for non-invasive quantification of physiology. The actual methodology of the study requires participants to donate 11 saliva samples over 24 hours under the supervision of technicians and in designated rooms. This is a rigorous experimental design, not a simple self-assessment. It is recommended to change the term to “novel non-invasive psychobiological profiling approach” or similar.

- Lines 139-150: Methodologically, it is not correct to describe the study in this section. I recommend that the authors delete this part or move it to the discussion section.

- In the last paragraph of the introduction, the text hypothesizes “IgA/LZM suppression.” However, the abstract and results of the article reveal that what was actually found was an activation/elevation of immunity in highly stressed students (IgA↑, lysozyme↑). I suggest revising the “Discussion” section to explicitly and clearly address why the authors expected immune suppression but ended up finding activation.

Methods

- Line 178: I suggest the authors change the verb tense to past tense: “Participants are permitted to maintain their regular eating...”

- The text states at the beginning that students were recruited between “March 3, 2023, and May 5, 2023” (a period spanning just over two months). However, a few lines below, the same paragraph concludes by stating that “Data collection occurred over three weeks.” I recommend that the authors define the exact period.

- Lines 198-201: What was the exact alpha level (e.g., 0.05)? What was the statistical power achieved (e.g., >80%)? What was the effect size detected?

- Line 196: The authors mention “A random selection of 285 students from the full sample was made for biomarker analysis,” but in the results section they mention “Totally, 262 salivary samples were collected at 3 PM and analyzed using ELISA.” How do the authors explain this difference?

Lines 217-219: I recommend that the authors remove the mention of the FSS and PSQI alphas from the PSS paragraph. Each paragraph should describe only its own assessment tool to maintain a logical reading flow.

Lines 241-242: I recommend that the authors clarify whether participants had to meet all criteria simultaneously (“and”) or only one of them (“or”).

Line 241: In the “Instruments and Data Collection” section, good sleep quality is defined as “PSQI ≤ 5.” However, this section states that to enter the Low Stress (LS) group, participants had to have “PSQI < 5.” If a student scores exactly 5 on the PSQI, do they qualify for the LS group or are they excluded? Mathematical notation should be perfectly consistent throughout the manuscript.

Line 253: I recommend that the authors use verbs in the past tense, given that these activities have already been carried out.

Lines 303-306: It is suggested to explicitly indicate which post hoc test was applied after the ANOVA (e.g., Bonferroni or other correction).

Lines 318-319: I suggest that the authors indicate "if the data were not normal, did they transform them logarithmically before applying ANOVA and Pearson? Or did they use nonparametric alternatives (such as Spearman's correlation or Kruskal-Wallis/Mann-Whitney tests)? I believe this should be clearly specified.

Results

- In one paragraph, the authors state that second-year students had significantly higher scores on the PSS compared to first-year students (p = 0.03). However, in the following paragraph, they conclude that “No significant variations in prevalence were identified across academic years (χ²=6.87, p=0.65).” Although mean scores may differ statistically without affecting the overall prevalence categorization, this distinction may not be entirely clear to readers. It would be helpful to include a brief clarifying statement indicating that, while raw mean scores varied (with second-year students showing higher values), the distribution across clinical categories (low, moderate, and high) did not differ significantly.

- Lines 401-402: The acronym MT is repeated in the title and IgA is omitted, even though it is also analyzed in this section.

- Lines 412.420 I recommend that the authors add the p-values to support the differences.

Discussion

- The discussion adequately integrates psychological and biological findings, which helps reinforce the impact of the study. However, a careful final review of the text is recommended, as there are some duplicate paragraphs that should be corrected.

Reviewer #2: This article examines the stress in undergrads by measuring many salivary biomarkers as well as questionnaires. This should provide insight into salivary biomarkers. The article merits publication; however, some points should be addressed first.

Title

-I'm not sure if "a cross-sectionaly study" should be added.

Abstract

-It would be nice to also note the p value when reporting r values.

Results

-The fonts in all the figures are very small and barely intelligible. It would be nice to adjust the make them more readable.

For example, the numbers are so tiny and just by not keeping decimal could make it more easily to read.

-Some values are in the range of 100,000 ng/ml. It would be more easily understandable if using ug/ml so the numbers are smaller amount.

-Fig2: It would be nice to also indicate which range of scores means mild/mod/severe

-PSQI in Fig 2 use score 7 which is different from the text that use 5. Please check

-Please check scores for FSS in Fig 2. I think there is some mistake. The % and score don't match with the text.

-For all figures, please use the symbol ≤ not <= as it's very difficult to read. Would also be nice to state HS LS groups in the x axes.

-Fig 3 and 5: It's impossible to tell which color represent what values as they are quite similar. There are 6 colors in the axes while in the figure there are 4. Maybe showing the box-plot like in Fig 2 would be easier to understand. Or should indicate the values in the text. ALso please avoid redundancy, like indicationg IgA (Immunoglobulin A), choose one.

-Fig 2E and 2F: it's a bit surprising that LS and HS groups had different PSQI and FSS since the box plot showed quite similar values. Please check.

-Pearson's correlations were actually very weak (for example, only r=0.14 for amylase vs IgA). It would be nice to show the scatter plot of these values in supplementary file.

-It would be nice to indicate the unit of the biomarkers values in figure legends or in the figures themselves.

-Fig 6 should really be adjusted as the current version is intelligible. It's too small. Actually the left and middle panels are not necessary as both are already shown in the right panels.

Discussion:

-It's very long and tedious to read. Some information is redundant or mentioned many times.

-It would also be very nice to make a paragraph shorter for readability.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review?  If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

PLOS Ment Health. doi: 10.1371/journal.pmen.0000717.r004

Decision Letter 1

Karli Montague-Cardoso

28 May 2026

PMEN-D-25-00591R1

The Hidden Burden of College Life: Stress, Sleep, and Salivary Biomarkers in Students — A Cross-Sectional Study

PLOS Mental Health

Dear Dr. Xu,

Thank you for submitting your revised manuscript to PLOS Mental Health. After careful consideration of the reviewer comments we invite you to submit another version of the manuscript that addresses the points raised during the review process. You will see from the comments raised that the reviewers felt that their points in the first round were not fully addressed. We require you to fully address the comments and may be unable to proceed further manuscript should you not do this. Thank you for your understanding.

Please submit your revised manuscript by Jul 26 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at mentalhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pmen/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Karli Montague-Cardoso

Staff Editor

PLOS Mental Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

publication criteria?>

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: Yes

Reviewer #2: I don't know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: No

**********

Reviewer #1: The authors complied with most of the requested guidelines regarding formatting, restructuring and methodological clarifications:

1. General format and structure

The manuscript was fully standardised in terms of formatting, using double spacing and 12-point Times New Roman font throughout all sections, including the references. Furthermore, the formal presentation of the article was enhanced by incorporating the methodological design into the title (“A Cross-Sectional Study”) and creating an appropriate short title of 68 characters. In the methodology section, the heading was correctly amended to “Materials and Methods”, in line with standard scientific nomenclature. Finally, the references were reorganised according to the Vancouver/PLOS format, correcting the chronological order and author punctuation, and removing residual metadata that remained in the document.

2. Abstract

The abstract was revised to improve the scientific accuracy of its statements. In particular, the wording relating to perceived stress was amended, replacing the phrase “clinically significant stress” with a more appropriate and objective description: “90.4% experienced moderate-to-high perceived stress”. Likewise, the finding associated with cortisol was reformulated with greater conceptual rigour, now described as “hypothalamic-pituitary-adrenal (HPA) axis dysregulation characterised by altered diurnal cortisol patterns”, thereby avoiding oversimplified interpretations. P-values were also included alongside correlation coefficients (r) in the main results reported in the abstract, thereby strengthening the statistical transparency of the summary.

3. Introduction

The introduction has been reorganised to improve its clarity and flow. The lengthy paragraph on signalling cascades, which made the text difficult to follow, has been split up and strategically summarised to make it easier to understand. Furthermore, premature findings and conclusions that were included in this section have been removed, thereby maintaining the structural coherence expected of a scientific introduction. Finally, the methodologically imprecise term ‘novel self-assessment paradigm’ was replaced by the expression ‘novel non-invasive psychobiological profiling approach’, which more accurately represents the methodological approach used in the study.

4. Materials and methods

The ‘Materials and methods’ section was strengthened in terms of both writing style and methodological rigour. Verbs were changed to the past tense to maintain narrative consistency, using expressions such as ‘Participants were permitted…’. The timeline of the study was also clarified, specifying that the recruitment process lasted two months, whilst the intensive data collection took place over three weeks. From a statistical perspective, the alpha significance level (0.05), statistical power greater than 80% and the expected effect size (Cohen’s d ≥ 0.5) were explicitly added. Furthermore, the use of the post-hoc LSD test following the ANOVA was detailed, as well as the application of Spearman’s correlations and logarithmic transformations for the analysis of non-normal data.

5. Results and Discussion

Relevant clarifications were incorporated into the results and discussion section to improve the interpretation of the findings. A specific explanation was added stating that, although there were variations in average scores across academic years, the categorisation of clinical prevalence remained largely unchanged. Furthermore, the discussion regarding the IgA/LZM markers was reorganised appropriately, moving the analysis of the paradoxical finding, where immune suppression was expected but activation was observed, to a more robust paragraph within the discussion. This new analysis proposes a transient response or an acute-over-chronic activation phenomenon as a possible explanation. Finally, the figures were optimised to improve the visualisation of the results: the former Figure 6, which was difficult to interpret due to its size, was divided into three separate figures (Figures 6, 7 and 8), and a supplementary appendix (S6 Fig) was also added with scatter plots to complement the analysis of the diurnal profiles.

Although the manuscript shows significant improvements and is generally of a high standard, there are still some areas that require further revision. In particular, certain corrections mentioned by the authors in their rebuttal letter have not been fully incorporated into the current version of the manuscript, and some methodological justifications could be strengthened to ensure greater clarity and consistency prior to formal acceptance.

1. Critical Discrepancy in PSQI Cut-off Points

A significant inconsistency remains in the definition of poor sleep quality. The methodological text sets the cut-off point as PSQI >5, whereas the caption for Figure 2 uses PSQI >7. In their response letter, the authors explicitly stated that this discrepancy had been corrected (“We thank the reviewer for identifying this discrepancy, which has been resolved accordingly”); however, upon reviewing the current version of the manuscript, I found that the problem persists. On page 16, lines 347–348, the caption for Figure 2 continues to state: “Participants with PSQI >7 were classified as having poor sleep quality”, contradicting the methodology described previously. I consider that this inconsistency must be corrected before acceptance, as it affects the internal coherence of the manuscript and reflects insufficient editorial review of the final version.

2. Inconsistency of Units in the Text vs. Figures.

I previously requested that the units of measurement shown in the figures be changed, replacing values expressed in ng/ml with more readable units, such as g/ml, in order to facilitate the visual interpretation of the data. In their response, the authors state that they made this change only in the text of the manuscript, but decided to retain the original units (“ng/ml” and “pg/ml”) in the heatmaps and boxplots, arguing that these correspond to the raw data obtained directly from the ELISA kits and that this would avoid potential conversion errors.

However, I consider that this justification does not adequately resolve the issue raised. Currently, the manuscript presents values such as “8.98 g/ml” in the text and “8980 ng/ml” in the figures simultaneously, which hinders comparative reading and may cause unnecessary confusion for the reader. From an editorial perspective, it is essential to maintain consistency in the units of measurement throughout the manuscript. I therefore recommend standardising the units used.

Reviewer #2: The authors have made effort to improve the manuscript. However, there are some issues of concern.

Actually, some of the issues have not been addressed even though the authors stated so.

-For example, Figure 2. There are still discrepancies between text and figure legend. Nothing changed.

In the text, PSQI was cutoff at 5 (Line 341) while in Figure legend PSQI cutoff was 7 (Line 348).

-The discrepancies regarding FSS values still remained. 51.02% = mod fatigue, 31.55%= severe fatigue (Line343-344). But in the Fig2C, FSS >5 is 51.02% and FSS 4-4.9 =31.55%.

-Fig 2 D-F showed graph as male female while the text explain difference between LS and HS groups withour differentiang sexes. The significant difference maker was on either male of female in the Fig which is misleading. Should clearly state significant difference compare with what group.

-This situation of sex in graph but show sig for combined sexes is the same with Fig 5. Also no values indicated in the Results. The authors state only higher/lower but no raw values.

-Line364-369, stating Factor 1 or 2 makes it confusing. The authors could simply indicate what each factor is without stating the Factor number.

-Well, the authors performed a lot of analysis and it's no surprise some must show significance but if one looks at the figure one would see how it is very unlikely that it would show real significance. This is especially the case with the Pearson correlation results. If one looks the graph for example cortisol vs amylase or melatonin vs amylase. even though the number is significant (howevery very low R at 0.14), one would not believe there is no correlation (S6 fig and S4 table).

-The Discussion could still be improved. For example, the intro regarding the significance of the study is mentioned in the first paragraph and repeated again in the fifth paragraph, interrupting the explanation of results.

-I do believe the article merits publication but the way it is presented doens't convince me very much. There is too much overclaim. And the writing should be improved. A lot of editing is needed.

-Also I don't see how the quality of the figures improve much regarding intelligibility. but if the is acceptable for the journal I have no further comment regarding this point. I feel some of the supplementary figure should be presented as real figure (not just a supplement) while some could be supplementary figure (for example Fig 4) but it's just my opinion.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review?  If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

PLOS Ment Health. doi: 10.1371/journal.pmen.0000717.r006

Decision Letter 2

Karli Montague-Cardoso

11 Aug 2026

PMEN-D-25-00591R2

The Hidden Burden of College Life: Stress, Sleep, and Salivary Biomarkers in Students — A Cross-Sectional Study

PLOS Mental Health

Dear Dr. Xu,

Thank you for submitting your revised manuscript to PLOS Mental Health. The reviewers have found this to be much improved and it is almost ready for acceptance pending a few more minor edits as suggested by reviewer 2 below. Given the minor nature of these comments, we will assess the final round of revisions in-house as opposed to sending it back to reviewers again.

Please submit your revised manuscript by Sep 09 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at mentalhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pmen/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Karli Montague-Cardoso

Staff Editor

PLOS Mental Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

publication criteria?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: Yes

Reviewer #2: I don't know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: All the suggestions were satisfactorily resolved by the others.

Reviewer #2: The authors have addressed all points raised.

However, there are some minor editorial issues that need to be addressed to improve the quality of the article.

-SAM is abbreviation. please write full name at first appearance.

-Line 166: Participants for diurnal sample collection

From the way it's written: 15 participants met LS criteria, and 18 met HS criteria. It seems strange that from 6xx subjects only 33 met the criteria. The LS is possible because all 3 criteria are required (PSS<28 + PSQI <5 + FSS <4) but for HS group only 1 criteria is required (either PSS >57 or PSQi >5 or FSS >5).

-Line 290: "MT concentrations showed positive correlations with concentrations of correlated positively with IgA."

Please correct.

-Mistake in Fig 7D and 7E. the graphs superimposed.

Also mistake in the Discussion (line413) "HS group showed elevated melatonin at 9:30"

Actually it's LS group, please check.

-Line 451: the blunted nighttime decline of amylase was not significantly different between HS and LS group, so cannot really conclude so.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review?  If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

PLOS Ment Health. doi: 10.1371/journal.pmen.0000717.r008

Decision Letter 3

Karli Montague-Cardoso

19 Aug 2026

The Hidden Burden of College Life: Stress, Sleep, and Salivary Biomarkers in Students — A Cross-Sectional Study

PMEN-D-25-00591R3

Dear Dr. Xu,

We are pleased to inform you that your manuscript 'The Hidden Burden of College Life: Stress, Sleep, and Salivary Biomarkers in Students — A Cross-Sectional Study' has been provisionally accepted for publication in PLOS Mental Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact mentalhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Mental Health.

Best regards,

Karli Montague-Cardoso

Staff Editor

PLOS Mental Health

***********************************************************

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Sociodemographic of participants.

    (DOCX)

    pmen.0000717.s001.docx (14.7KB, docx)
    S2 Table. FSS, PSS, and PSQI scores comparisons among the grades.

    (DOCX)

    pmen.0000717.s002.docx (17.1KB, docx)
    S3 Table. Pearson correlation of PSQI, PSS, and FSS.

    (DOCX)

    pmen.0000717.s003.docx (12.9KB, docx)
    S4 Table. Pearson correlation of alpha-amylase, IgA, CHGA, MT, LZM, and cortisol.

    (DOCX)

    pmen.0000717.s004.docx (13.9KB, docx)
    S5 Table. Basic demographic information of participants recruited for diurnal sample collecting.

    (DOCX)

    pmen.0000717.s005.docx (18.4KB, docx)
    S1 Fig. Scatter plots of MT, CHGA, IgA, LZM, and cortisol versus alpha‑amylase.

    (TIF)

    pmen.0000717.s006.tif (1.9MB, tif)
    S1 Text. STROBE Statement—Checklist of items that should be included in reports of cross-sectional studies.

    (DOCX)

    pmen.0000717.s007.docx (29.8KB, docx)
    Attachment

    Submitted filename: Response letter.docx

    pmen.0000717.s008.docx (128.3KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pmen.0000717.s009.docx (28.4KB, docx)
    Attachment

    Submitted filename: Response to reviewers.doc

    pmen.0000717.s010.doc (36.1KB, doc)

    Data Availability Statement

    The data contain potentially identifiable information from a specific participant group, and participants did not provide consent for public data sharing. All data access requests will be reviewed and approved by the ethics committee to ensure strict adherence to participant consent and privacy protections. This ensures that data sharing remains possible for legitimate scientific purposes while maintaining appropriate institutional oversight. Contact for data access: WKU Ethics Committee, Wenzhou-Kean University, orspdept@wku.edu.cn The corresponding author, Hongyu Xu, xuhy198169@163.com; hxu@kean.edu.


    Articles from PLOS Mental Health are provided here courtesy of PLOS

    RESOURCES